Advertisement
Advertisement
Trending on Dermatology Times
1
Other People’s Money and the Rise of Private Equity in Dermatology, Part 1: Behind the Buyout
2
How Molecular Tools Are Reshaping Risk Stratification in Cutaneous SCC
3
Imsidolimab Receives European Orphan Designation for Generalized Pustular Psoriasis
4
ICYMI: FDA Clears RHA Redensity Eye for Infraorbital Hollowing
5